Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62054253 | chr16:89896932 | T/C | 0.000207 | 171 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs62054257 | chr16:89900195 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62054258 | chr16:89900495 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62054259 | chr16:89900500 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62054571 | chr16:90063901 | A/C | 9.47E-9 | 173 | 25.77 | 20.37 | 6.62 | KM Plot |
PCPG | rs62054572 | chr16:90065941 | G/C | 9.47E-9 | 173 | 25.77 | 20.37 | 6.62 | KM Plot |
PCPG | rs62054574 | chr16:90067310 | A/G | 1.07E-8 | 172 | 25.77 | 23.12 | 6.62 | KM Plot |
PCPG | rs62054580 | chr16:90079569 | G/C | 1.27E-8 | 173 | 25.67 | 20.28 | 6.62 | KM Plot |
PCPG | rs62054599 | chr16:89808850 | C/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054601 | chr16:89811751 | C/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054604 | chr16:89812199 | C/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054605 | chr16:89812201 | T/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054609 | chr16:89816569 | C/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054610 | chr16:89816920 | G/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054611 | chr16:89817017 | T/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |